Presentation is loading. Please wait.

Presentation is loading. Please wait.

Structure of grepafloxacin relative to activity and safety profile

Published byBrooke Hardy Modified over 5 years ago

Similar presentations

Presentation on theme: "Structure of grepafloxacin relative to activity and safety profile"— Presentation transcript:

1 Structure of grepafloxacin relative to activity and safety profile
David C. Hooper  Clinical Microbiology and Infection  Volume 4, Pages S15-S20 (March 1998) DOI: /j tb00684.x Copyright © 1998 European Society of Clinical Infectious Diseases Terms and Conditions

2 Figure 1 The structure-activity relationships of fluoroquinolones. Reproduced with kind permission of the Oxford University Press, from Domegla [2]). Clinical Microbiology and Infection 1998 4, S15-S20DOI: ( /j tb00684.x) Copyright © 1998 European Society of Clinical Infectious Diseases Terms and Conditions

Download ppt "Structure of grepafloxacin relative to activity and safety profile"

Similar presentations

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages 19-23.

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Laboratory diagnosis and biosafety issues of biological warfare agents

Laboratory diagnosis and biosafety issues of biological warfare agents
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 

C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
In-vitro interaction of azithromycin and fluoroquinolones against gram-positive and gram-negative bacteria  Matthew W. Ruble, Deborah H. Gilbert, Stephen.

In-vitro interaction of azithromycin and fluoroquinolones against gram-positive and gram-negative bacteria  Matthew W. Ruble, Deborah H. Gilbert, Stephen.
Grepafloxacin: microbiological properties

Grepafloxacin: microbiological properties
Gut bacterial microbiota and obesity

Gut bacterial microbiota and obesity
Approach to diagnosis of infective endocarditis

Approach to diagnosis of infective endocarditis
Anthrax, tularemia, plague, ebola or smallpox as agents of bioterrorism: recognition in the emergency room  B.A. Cunha  Clinical Microbiology and Infection 

Anthrax, tularemia, plague, ebola or smallpox as agents of bioterrorism: recognition in the emergency room  B.A. Cunha  Clinical Microbiology and Infection 
The changing epidemiology of severe infections in the ICU

The changing epidemiology of severe infections in the ICU
Herpes zoster in non-hospitalized children

Herpes zoster in non-hospitalized children
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 

C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
Hydatid disease Clinical Microbiology and Infection

Hydatid disease Clinical Microbiology and Infection
Link between intracellular pathogens and cardiovascular diseases

Link between intracellular pathogens and cardiovascular diseases
How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development  R. Bax  Clinical Microbiology.

How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development  R. Bax  Clinical Microbiology.
How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach  D. Guillemot  Clinical Microbiology.

How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach  D. Guillemot  Clinical Microbiology.
In vitro activity, postantibiotic effect and human monocyte activity of grepafloxacin against Legionella species  Jacques Dubois, Claude St-Pierre  Clinical.

In vitro activity, postantibiotic effect and human monocyte activity of grepafloxacin against Legionella species  Jacques Dubois, Claude St-Pierre  Clinical.
Holt Hanne M. , Søgaard Per , Gahrn-Hansen Bente  

Holt Hanne M. , Søgaard Per , Gahrn-Hansen Bente  
Vector control: a cornerstone in the malaria elimination campaign

Vector control: a cornerstone in the malaria elimination campaign
Fourth-generation cephalosporins: a review of in vitro activity, pharmacokinetics, pharmacodynamics and clinical utility  Javier Garau, Walter Wilson,

Fourth-generation cephalosporins: a review of in vitro activity, pharmacokinetics, pharmacodynamics and clinical utility  Javier Garau, Walter Wilson,
C-3′Quaternary Ammonium Cephems, a New Wave of Cephalosporins

C-3′Quaternary Ammonium Cephems, a New Wave of Cephalosporins

Similar presentations

Ads by Google